USBC knowlabs.co: Koefisien utang jangka dawa marang modal

The price evolution of USBC Inc (USBC) demonstrates a trend where the indicator stands at 0.00. The holding company is currently focused on FDA certification of its Bio-RFID system for non-invasive glucose analysis. The business is implementing AI solutions that automate the collection of biometric data without skin punctures. This strategy renders the company independent of market volatility, as its success relies exclusively on scientific and technical progress in the field of diabetology.

To minimize entry risks, it is essential to assess the business's dependence on external financing via the ratio of long-term liabilities to equity. Analyzing the level of long-term debt relative to equity reveals the extent to which investments in USBC Inc. (USBC) health monitoring IT systems rely on borrowed funds, thereby determining the holding's financial stability and solvency.